Publication, Part of Tumour Genomic Testing Data Dashboard (previously called the Somatic Molecular Dashboard)
Tumour Genomic Testing Data Dashboard 2016-2022
Summary
The genetic alterations giving rise to and occurring in cancers (i.e. somatic aberrations) can be important markers for prognosis and treatment options. Increasingly, diagnostic tumour genomic testing (to detect such somatic aberrations) is being carried out as standard care for various tumour types. Since 2016 the National Disease Registration Service (NDRS) has collected molecular testing (i.e. testing of the tumour’s genetic material) data in one central data set covering all English tumour diagnoses. Since 2019, the NDRS has also collected data on immunohistochemistry (IHC) protein tests carried out on PD-L1 and MMR proteins. This Tumour Genomic Testing Data dashboard exists to let users explore, at top level, the data found in this dataset.
Highlights
This publication has been moved to the NDRS website.
Last edited: 13 November 2025 9:32 am